Stem-cell law varies a lot by country — some allow it, some restrict embryonic cells, many treat most uses as investigational. Pick your country for an indicative read, then see the full comparison. Indicative only — laws change; always verify current national rules.
| Country | Stance | Embryonic / framework | Therapy status & note |
|---|---|---|---|
| États-Unis | Regulated | Legal (limited federal funding) | Mostly investigational; FDA tightening on autologous 'point-of-care' |
| Canada | Regulated | Legal, restricted | Strict, mirrors US; mostly trials/approved indications |
| Royaume-Uni | Regulated | Permitted (HFEA) | Research permitted; therapy via approved use or trials |
| Allemagne | Restrictive | Embryonic largely banned | Adult/iPSC focus; premium private clinics; highest EU price |
| Italy | Restrictive | Embryonic banned | Adult-cell only; patients often travel |
| Austria | Restrictive | Embryonic banned | Adult-cell focus; patients travel |
| Espagne | Permissive | Permitted | Active research + regulated therapy |
| Pays-Bas | Permissive | Permitted | Research permitted; regulated |
| Sweden | Permissive | Permitted | Research permitted |
| Belgium | Permissive | Permitted | Research permitted |
| Bulgaria (EU) | Regulated | EU framework | EU GMP private clinics; cheapest EU on indicative pricing |
| Serbie | Permissive | Permitted | Non-EU; established private clinics, lower cost |
| Mexique | Permissive | Permitted | Popular with US/Canada; non-EU oversight |
| Inde | Permissive | Permitted (variable) | Low absolute cost; quality varies widely |
| Thaïlande | Permissive | Permitted | Wellness + dental-pulp focus; non-EU |
| Turquie | Permissive | Permitted (regulated) | Growing hub; non-EU |
| Chine | Regulated | State-led, uneven | Large domestic sector; iPSC research |
| Corée du Sud | Restrictive | Strict approvals | iPSC leader; hard to access privately |
| Japon | Regulated | Conditional fast-track (ATMP) | Conditional-approval pathway; advanced |
| UAE / Gulf | Regulated | Emerging framework | Newer regulated centres; patients also travel out |
| Australia | Regulated | Permitted, regulated | TGA-regulated; mostly trials/approved use |
Click any column header to sort.
Sources: ISSCR, national regulators (FDA/EMA/HFEA/TGA), peer-reviewed reviews of stem-cell tourism. Indicative; verify current law for your situation.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite